Back to search

Article

A Comprehensive SARS-CoV-2 Genomic Analysis Identifies Potential Targets for Drug Repurposing

2020-06-05

Abstract excerpt

<h4>Background: </h4> The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is a novel human coronavirus strain (HCoV) initially reported in December 2019 in Wuhan City, China causing pneumonia-like symptoms and other respiratory tract illness. It’s higher transmission and infection rate has successfully enabled it to have a global spread over a matter of small time. With 6,529,240 cases and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
22e95685-fa50-5fdb-b56e-655063aa333a
DOI
10.26434/chemrxiv.12430919.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Comprehensive SARS-CoV-2 Genomic Analysis Identifies Potential Targets for Drug RepurposingDOI 10.26434/chemrxiv.12430919.v1
A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposingSemantic proximity
Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposingSemantic proximity
An Integrative in Silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS-CoV-2 Main ProteaseSemantic proximity
Integrated Docking and Enhanced Sampling Based Selection of Repurposing Drugs for SARS-CoV-2 by Targeting Host Dependent FactorsSemantic proximity
A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19Semantic proximity
Phylogenetic analysis and In silico Screening of drug targets for ACE2 in Human and Spike Glycoprotein in Sars-CoV-2 for control of COVID19Semantic proximity
The SARS-CoV-2 replication-transcription complex is a priority target for broad-spectrum pan-coronavirus drugsSemantic proximity
An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment StrategiesSemantic proximity
Repurposing drugs for treatment of SARS-CoV-2 infection: Computational design insights into mechanisms of actionSemantic proximity
Identification of drugs targeting multiple viral and human proteins using computational analysis for repurposing against COVID-19Semantic proximity
Identification of Drugs Targeting Multiple Viral and Human Proteins Using Computational Analysis for Repurposing Against COVID-19Semantic proximity
Virtual screening FDA approved drugs against multiple targets of SARS‐CoV‐2Semantic proximity
Select a neighboring publication to make it the new centre.